With prices unlikely to run up sharply, genuine buyers can start readying deals before the festival season starts.
With the Union Budget over, it is a good time to start the rebalancing exercise. Take cues from last year's market performance
Stocks such as NIIT, Punj Lloyd, Gati, Welspun India and BEML are favourites of the trading community.
Though India has been one of the best-performing markets in the last two months, it has lagged some of its emerging market peers such as the Philippines, Thailand and South Africa.
Because of local and global problems, inflation pressures may continue, helping these schemes perform better.
In front-running case, some fund houses have settled with Sebi and paid the amount lost to trustees.
Firms with low promoter holding may get to buy shares from secondary market.
Sebi's suggestions are good but investors should not become overconfident.
Without proper files, approaching the court isn't quite helpful.
Equity markets are currently difficult to gauge as the market has probably priced in a lot of things ahead of actual events.
Shortage of seeds, threat of El Nino expected to restrict sowing.
The proposed exchange is likely to be almost as big as Mumbai's Bharat Diamond Bourse, now said to be fully occupied.
Having successfully implemented the 25 per cent free-float norm for private companies, the Securities and Exchange Board of India now wants the government to pare its holdings in public-sector undertakings to below 75 per cent.
Instead of being carried away by Friday's historic election verdict, savvy investors were seen taking money off the table, after the benchmark Sensex rallied about 1,500 points in intra-day trade.
Sensex gains 2.4%, Nifty crosses 7,000; investors feel exit polls have vindicated their stand
Current FDI norms allow a foreign airline to hold up to 49 per cent in a domestic carrier.
MCX has been struggling to raise funds with a rights issue, ending on Thursday.
The new provisions strengthen the hands of minority shareholders and will improve corporate governance.
Sun Pharma's offer was tempting because Ranbaxy was too busy fighting fires in the US to concentrate on operations.
Could address the concerns over Companies Act provision on the issue